Indian Pharmacopoeia Commission

Indian Pharmacopoeia Commission (IPC) is an autonomous institution of the Ministry of Health and Family Welfare which sets standards for all drugs that are manufactured, sold and consumed in India.^[3] The set of standards are published under the title Indian Pharmacopoeia (IP) which has been modeled on and historically follows from the British Pharmacopoeia. The standards that are in effect since 1 December 2010,^[4] are the Indian Pharmacopoeia 2010 (IP 2010). The Pharmacopoeia 2014 was released by Health Minister Ghulam Nabi Azad on 4 November 2013.^[5] The Pharmacopoeia 2018 was released by Secretary, Ministry of Health & Family Welfare, Government of India.^[5]

I.P., the abbreviation of 'Indian Pharmacopoeia' is familiar to the consumers in the Indian sub-continent as a mandatory drug name suffix. Drugs manufactured in India have to be labelled with the mandatory non-proprietary drug name with the suffix I.P.^{[citation needed]} This is similar to the B.P. suffix for British Pharmacopoeia and the U.S.P. suffix for the United States Pharmacopeia.

The IPC was formed according to the Indian Drugs and Cosmetics Act of 1940 and established by executive orders of the Government of India in 1956.^{[citation needed]}